ImmunoGenesis, Inc.
Re-envisioning cold tumor treatment. Our deliberate drug development strategy targets mechanisms of immune resistance.
14 employees · est. 2019 · Houston, United States
Sling Therapeutics
Focused on late-stage development of an oral small molecule for the treatment of thyroid eye disease (TED).
12 employees · est. 2020 · Ann Arbor, United States
ImmunoGenesis, Inc. is the older company (2019 vs 2020).
Side-by-Side Comparison
| Metric | ImmunoGenesis, Inc. | Sling Therapeutics |
|---|---|---|
| Founded | ||
| Founded | 2019 older | 2020 |
| Headquarters | ||
| Headquarters | Houston, United States | Ann Arbor, United States |
| Employees | ||
| Employees | 14 | 12 |
| Industry | ||
| Industry | Biotechnology, Health Care, Health and Wellness | Biopharma, Biotechnology, Pharmaceutical |
| Funding Stage | ||
| Funding Stage | Series Unknown | Series A |
| Total Funding | ||
| Total Funding | $28.00M | $35.00M |
| Funding Rounds | ||
| Funding Rounds | 4 | 1 |
| Services | ||
| Services | Not tracked yet | Development of Linsitinib for Thyroid Eye Disease, Conducting Clinical Trials, Therapeutic Pipeline Development, Medical Research and Innovation |
| Target Customers | ||
| Target Customers | Not tracked yet | Patients with Thyroid Eye Disease, Caregivers, Healthcare Providers, Medical Researchers |
| Taxonomy | ||
| Taxonomy | Immuno-oncology, Biopharmaceutical, Drug Development, Immune Resistance, Immune-excluded Tumors, Immunotherapy, Clinical-stage, Immune Response, Tumor Pathology, Cancer Treatment, Immune System, Therapy Development | Thyroid Eye Disease, Biopharmaceutical, Clinical-stage Development, Oral Small Molecule, Drug Development, Autoimmune Diseases, Endocrinology, Ophthalmology, Hyperthyroidism, Clinical Research, Molecular Engineering, Chemistry, Patient Advocacy, Graves' Disease |
| Website | ||
| Website | immunogenesis.com | slingtx.com |
About ImmunoGenesis, Inc.
ImmunoGenesis, Inc. is a clinical-stage immuno-oncology biopharmaceutical company focused on re-envisioning the treatment of "cold" tumors, particularly immune-excluded tumors. These tumors, which account for over half of all cancers, are resistant to current immunotherapies due to mechanisms that s...
About Sling Therapeutics
Sling Therapeutics, a clinical-stage company founded in 2020, is making significant strides in the biopharma and biotechnology industries. The company is headquartered in the United States and focuses on the late-stage development of an oral small molecule designed to treat thyroid eye disease (TED)...
We will tell you when either one moves
BounceWatch watches ImmunoGenesis, Inc. and Sling Therapeutics for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at ImmunoGenesis, Inc. and Sling Therapeutics — by email.
Frequently Asked Questions
Compare ImmunoGenesis, Inc. with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at ImmunoGenesis, Inc. on 12 Sep 2024, and Sling Therapeutics on 11 Mar 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.